Strategic Partnerships GATC Biotech has a track record of cross-institution collaborations, including a 2022 agreement with Fraunhofer ILT and other partners, signaling strong co-development capabilities and credibility with research buyers. This presents a sales opportunity to pursue joint projects with European universities, research institutes, and industry partners focused on genome sequencing and bioinformatics services, enabling longer-term engagements beyond single projects.
Liquid Biopsy GATC's GATCLIQUID service family and full-length transcript isoform characterization position the company for clinical-grade sequencing applications, particularly in oncology, circulating tumor DNA diagnostics, and precision medicine. This creates a sales angle to engage pharmaceutical companies, diagnostic labs, and hospital networks seeking end-to-end sequencing plus circulating DNA analysis with validation-ready workflows.
European Leadership Positioned as Europe’s leading service provider in DNA sequencing and bioinformatics, and with Eurofins' backing since 2017, GATC offers credibility, scale, and a stable platform to win European mid-market contracts. Leverage the Eurofins network for cross-selling complementary services or joint bids to academic consortia and biotech firms expanding their sequencing capacity in Europe.
End to End Solutions GATC supports projects from individual samples to complete genome projects, combining sequencing and bioinformatics evaluation under one roof. This one-stop capability is attractive to customers seeking streamlined project management, bundled pricing, and long-term support agreements, including ongoing data analysis and re-annotation services.
Mid-Sized Growth With a 51-200 employee base and a growth-minded portfolio, GATC is well positioned to win business from mid-sized biotech firms, CROs, and academic core facilities that need flexible capacity and scalable sequencing workflows. A sales plan could feature pilot programs, tiered pricing, and fast onboarding to convert inquiries into repeat projects.